Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1996 1
1999 1
2004 1
2005 1
2007 1
2009 2
2010 2
2012 1
2014 1
2018 2
2019 1
2020 2
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Chemotherapy: present and future.
Terry AR, Plotkin SR. Terry AR, et al. Otolaryngol Clin North Am. 2012 Apr;45(2):471-86, x. doi: 10.1016/j.otc.2011.12.013. Otolaryngol Clin North Am. 2012. PMID: 22483828 Review.
Bilateral VS are the hallmark of neurofibromatosis type II, commonly leading to complete deafness and cranial nerve deficits as a result of tumor progression or treatment with surgery or radiation. ...The article also defines and recommends the use of specific cl …
Bilateral VS are the hallmark of neurofibromatosis type II, commonly leading to complete deafness and cranial nerve deficits a …
Intravenous azithromycin-induced ototoxicity.
Bizjak ED, Haug MT 3rd, Schilz RJ, Sarodia BD, Dresing JM. Bizjak ED, et al. Pharmacotherapy. 1999 Feb;19(2):245-8. doi: 10.1592/phco.19.3.245.30930. Pharmacotherapy. 1999. PMID: 10030778
Current dosing guidelines for intravenous azithromycin can result in much higher serum concentrations than is seen with oral administration. We describe a 47-year-old woman who developed complete deafness after receiving 8 days of intravenous azithromycin....
Current dosing guidelines for intravenous azithromycin can result in much higher serum concentrations than is seen with oral administration. …
Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.
Harabuchi Y, Kishibe K, Tateyama K, Morita Y, Yoshida N, Okada M, Kunimoto Y, Watanabe T, Inagaki A, Yoshida T, Imaizumi M, Nakamura T, Matsunobu T, Kobayashi S, Iino Y, Murakami S, Takahashi H, Tono T. Harabuchi Y, et al. Auris Nasus Larynx. 2021 Feb;48(1):2-14. doi: 10.1016/j.anl.2020.07.004. Epub 2020 Aug 5. Auris Nasus Larynx. 2021. PMID: 32768313 Free article. Review.
Severe sequelae such as facial palsy, hypertrophic pachymeningitis, complete deafness, and subarachnoid hemorrhage resulting in death can also occur. In this review, we introduce the clinical features, diagnostic criteria, and treatment strategies recommended …
Severe sequelae such as facial palsy, hypertrophic pachymeningitis, complete deafness, and subarachnoid hemorrhage resulting i …
Threshold monitoring of intraoperative auditory steady-state responses for ossiculoplasty surgery.
Liu Q, Feng G, Shang Y, Chi C, Qiao Y, Gao Z. Liu Q, et al. Acta Otolaryngol. 2018 Jul;138(7):625-632. doi: 10.1080/00016489.2018.1436767. Epub 2018 Mar 5. Acta Otolaryngol. 2018. PMID: 29504434 Clinical Trial.
The interaural attenuation of the SFE was tested in patients with unilateral complete deafness and contralateral normal hearing (10 patients). Self-designed SFEs were used to measure the chirp-evoked auditory steady-state responses (Chirp-ASSR) threshold of patients …
The interaural attenuation of the SFE was tested in patients with unilateral complete deafness and contralateral normal hearin …
Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene.
Iida Y, Wakiguchi H, Okazaki F, Nakamura T, Yasudo H, Kubo M, Sugahara K, Yamashita H, Suehiro Y, Okayama N, Hashimoto K, Iwamoto N, Kawakami A, Aoki Y, Takada H, Ohga S, Hasegawa S. Iida Y, et al. Clin Rheumatol. 2019 Mar;38(3):943-948. doi: 10.1007/s10067-018-4331-8. Epub 2018 Oct 18. Clin Rheumatol. 2019. PMID: 30338413
The early intervention of IL-1beta blockade may reduce the chance of complete deafness in patients with CAPS....
The early intervention of IL-1beta blockade may reduce the chance of complete deafness in patients with CAPS....
Palmoplantar papules and hyperkeratosis in a deaf man.
Taylor SL, Kwatra SG, McMichael AJ. Taylor SL, et al. Skinmed. 2014 Mar-Apr;12(2):107-9. Skinmed. 2014. PMID: 24933850
He tried various topical medications, none of which were successful in minimizing the lesions on the hands and feet. Pertinent review of systems was positive for complete deafness diagnosed at 9 months of age. The patient did not speak and used sign language to comm …
He tried various topical medications, none of which were successful in minimizing the lesions on the hands and feet. Pertinent review of sys …
Autoimmune sensorineural hearing loss: clinical course and treatment outcome.
Loveman DM, de Comarmond C, Cepero R, Baldwin DM. Loveman DM, et al. Semin Arthritis Rheum. 2004 Oct;34(2):538-43. doi: 10.1016/j.semarthrit.2003.10.002. Semin Arthritis Rheum. 2004. PMID: 15505769
The 3 subjects who were anti-68-kd antibody-negative were steroid-unresponsive, and 1 progressed to complete deafness. CONCLUSIONS AND RELEVANCE: This series of patients with ASHL suggests a more variable and benign course with a better prognosis than previously rep …
The 3 subjects who were anti-68-kd antibody-negative were steroid-unresponsive, and 1 progressed to complete deafness. CONCLUS …
High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss.
Souleymane MB, Piubello A, Lawan IM, Hassane-Harouna S, Assao-Neino MM, Soumana A, Hamidou-Harouna Z, Gagara-Issoufou A, Ortuño-Gutiérrez N, Roggi A, Schwoebel V, Mamadou S, Lynen L, De Jong B, Van Deun A, Decroo T. Souleymane MB, et al. Eur Respir J. 2021 Jan 21;57(1):2002250. doi: 10.1183/13993003.02250-2020. Print 2021 Jan. Eur Respir J. 2021. PMID: 32703777 Free article.
In 2016, two patients developed severe ototoxicity despite switching to linezolid. Since 2017, no patient developed severe hearing loss or complete deafness. Severe haematological toxicity was observed in 18.1% (six out of 33) of patients on linezolid, none of which …
In 2016, two patients developed severe ototoxicity despite switching to linezolid. Since 2017, no patient developed severe hearing loss or …
Transtympanic corticoid therapy for acute profound hearing loss.
Lautermann J, Sudhoff H, Junker R. Lautermann J, et al. Eur Arch Otorhinolaryngol. 2005 Jul;262(7):587-91. doi: 10.1007/s00405-004-0876-z. Epub 2005 Mar 3. Eur Arch Otorhinolaryngol. 2005. PMID: 15744509
The prognosis of idiopathic sudden hearing loss depends on its severity; acute complete deafness, for example, has a particularly bad prognosis. The treatment of acute deafness is based on a systemic application of corticosteroids. ...
The prognosis of idiopathic sudden hearing loss depends on its severity; acute complete deafness, for example, has a particula …
Barotrauma and decompression illness of the inner ear: 46 cases during treatment and follow-up.
Klingmann C, Praetorius M, Baumann I, Plinkert PK. Klingmann C, et al. Otol Neurotol. 2007 Jun;28(4):447-54. doi: 10.1097/MAO.0b013e318030d356. Otol Neurotol. 2007. PMID: 17417111
The hearing loss ranged from an unobtrusive difference of 10 dB between the ears up to complete deafness. Three patients were subjected to tympanoscopy because of suspected rupture of the round window membrane. ...
The hearing loss ranged from an unobtrusive difference of 10 dB between the ears up to complete deafness. Three patients were …
15 results